XML 87 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 19 - Segment Reporting - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Product revenue, net $ 22,934 $ 26,279 $ 45,033 $ 53,934
Income (loss) from operations 2,364 (6,868) 860 (8,676)
Depreciation and amortization 1,899 1,853 3,840 3,708
Stock-based compensation expense 820 3,067 1,750 4,244
Impairment expense 0 2,600 0 2,600
Rx Segment [Member]        
Product revenue, net 18,748 18,029 36,565 36,681
Income (loss) from operations 3,146 (5,464) 2,280 (6,457)
Depreciation and amortization 1,510 1,572 3,064 3,146
Stock-based compensation expense 707 2,987 1,432 4,149
Impairment expense   2,600   2,600
Consumer Health [Member]        
Product revenue, net 4,186 8,250 8,468 17,253
Income (loss) from operations (782) (1,404) (1,420) (2,219)
Depreciation and amortization 389 281 776 562
Stock-based compensation expense $ 113 80 $ 318 95
Impairment expense   $ 0   $ 0